China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project
- Written by PR Newswire
HAIKOU, China, Dec. 5, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the Acquisition of Dry Eye Disease Therapeutic Device Project.
- This device has a...














